The mechanism by which oxygen bound in UO2(2+) exchanges with that from water under strong alkaline conditions remains a subject of controversy. Two recent NMR studies independently revealed that the key intermediate species is a binuclear uranyl(VI) hydroxide, presumably of the stoichiometry [(UO2(OH)4(2-))(UO2(OH)5(3-))]. The presence of UO2(OH)5(3-) in highly alkaline solution was postulated in earlier experimental studies, yet the species has been little characterized. Quantum-chemical calculations (DFT and MP2) show that hydrolysis of UO2(OH)4(2-) yields UO3(OH)3(3-) preferentially over UO2(OH)5(3-). X-ray absorption spectroscopy was used to study the uranium(VI) speciation in a highly alkaline solution supporting the existence of a species with three U-O bonds, as expected for UO3(OH)3(3-). Therefore, we explored the oxygen exchange pathway through the binuclear adduct [(UO2(OH)4(2-))(UO3(OH)3(3-))] by quantum-chemical calculations. Assuming that the rate-dominating step is proton transfer between the oxygen atoms, the activation Gibbs energy for the intramolecular proton transfer within [(UO2(OH)4(2-))(UO3(OH)3(3-))] at the B3LYP level was estimated to be 64.7 kJ mol(-1). This value is in good agreement with the activation energy for "yl"-oxygen exchange in [(UO2(OH)4(2-))(UO2(OH)5(3-))] obtained from experiment by Szabó and Grenthe (Inorg. Chem. 2010, 49, 4928-4933), which is 60.8 ± 2.4 kJ mol(-1). Both the presence of UO3(OH)3(3-) and the scenario of an "yl"-oxygen exchange through a binuclear species in strong alkaline solution are supported by the present study.
No takes yet. Share an insight, caveat, or question.
Moll et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: